Literature DB >> 31131376

Sonographic Features of the Liver Among Females with Type 2 Diabetes.

Bárbara L Riestra-Candelaria1, Loida A González-Rodríguez2, Wilma Rodriguez-Mojica3, Luis E Vázquez-Quiñones4, Juan Carlos Jorge1.   

Abstract

The craniocaudal (CC) length of the right lobe of the liver (RLL), liver texture, size of the main portal vein, and hemodynamics of the hepatic artery, were sonographically evaluated in female diabetic and non-diabetic patients. A One-way ANOVA, a Tukey's post-hoc test, and a Kruskal-Wallis with post-hoc Dunn's test, were employed. Non-symptomatic differences in liver anatomy were detected among non-controlled type 2 diabetes patients. They exhibited the longest CC length of the RLL (p = 0.04) as well as an enlarged main portal vein (p = 0.04). Hepatic artery resistive index (RI) was higher among controlled type 2 diabetes patients (p = 0.04). These differences were not attributed to fatty infiltration. Non-controlled type 2 diabetes patients exhibited significantly higher alanine aminotransferase, lower high-density lipoprotein cholesterol, and higher triglyceride levels, than in non-type 2 diabetes patients. Longitudinal sonography may provide valuable diagnostic information in the management of type 2 diabetes.

Entities:  

Keywords:  liver; right liver lobe; sonography; type 2 diabetes

Year:  2019        PMID: 31131376      PMCID: PMC6530923          DOI: 10.1177/8756479319834927

Source DB:  PubMed          Journal:  J Diagn Med Sonogr        ISSN: 1552-5430


  31 in total

1.  Abdominal adiposity values associated with established body mass indexes in white, black and hispanic Americans. A study from the Third National Health and Nutrition Examination Survey.

Authors:  I S Okosun; S H Tedders; S Choi; G E Dever
Journal:  Int J Obes Relat Metab Disord       Date:  2000-10

2.  Abnormal liver function test predicts type 2 diabetes: a community-based prospective study.

Authors:  Nam H Cho; Hak C Jang; Sung Hee Choi; Hyung R Kim; Hong Kyu Lee; Juliana C N Chan; Soo Lim
Journal:  Diabetes Care       Date:  2007-07-12       Impact factor: 19.112

3.  Liver biopsy.

Authors:  Don C Rockey; Stephen H Caldwell; Zachary D Goodman; Rendon C Nelson; Alastair D Smith
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

Review 4.  Causes and metabolic consequences of Fatty liver.

Authors:  Norbert Stefan; Konstantinos Kantartzis; Hans-Ulrich Häring
Journal:  Endocr Rev       Date:  2008-08-21       Impact factor: 19.871

5.  Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus.

Authors:  C G Solomon; F B Hu; A Dunaif; J Rich-Edwards; W C Willett; D J Hunter; G A Colditz; F E Speizer; J E Manson
Journal:  JAMA       Date:  2001-11-21       Impact factor: 56.272

6.  High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes.

Authors:  Barbora Vozarova; Norbert Stefan; Robert S Lindsay; Aramesh Saremi; Richard E Pratley; Clifton Bogardus; P Antonio Tataranni
Journal:  Diabetes       Date:  2002-06       Impact factor: 9.461

Review 7.  Diabetes and liver disease: an ominous association.

Authors:  Simona Moscatiello; Rita Manini; Giulio Marchesini
Journal:  Nutr Metab Cardiovasc Dis       Date:  2007-01       Impact factor: 4.222

Review 8.  Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences.

Authors:  Isabelle A Leclercq; Alain Da Silva Morais; Ben Schroyen; Noémi Van Hul; Albert Geerts
Journal:  J Hepatol       Date:  2007-04-16       Impact factor: 25.083

9.  Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance.

Authors:  David E Kelley; Therese M McKolanis; Refaat A F Hegazi; Lewis H Kuller; Satish C Kalhan
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-10       Impact factor: 4.310

10.  Waist circumference and not body mass index explains obesity-related health risk.

Authors:  Ian Janssen; Peter T Katzmarzyk; Robert Ross
Journal:  Am J Clin Nutr       Date:  2004-03       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.